Summit Therapeutics Inc. SMMT
15.80 USD +1.00 (+6.76%)
At closeNov 3, 2026, 4:00 PM EST
15.80 0.00 0.00%
After hours · Nov 3, 4:00 PM ET
14.86 Day range 16.42
12.07 52-week range 29.23
- YTD
- -9.66%
- 1 year
- -13.28%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -1.09B | -226.00M | -609.65M | -72.09M | -86.19M | |
| -1.08B | -221.31M | -614.93M | -78.78M | -88.60M | |
| -0.014 | -0.003 | -0.01 | -0.004 | -0.007 |
Balance sheet
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 225.58M | 105.19M | 71.42M | 648.61M | 71.79M | |
| 751.18M | 435.56M | 202.95M | 664.17M | 113.37M | |
| 92.32M | 46.81M | 125.26M | 537.51M | 30.09M | |
| 20.89M | 7.22M | 106.10M | 518.76M | 2.78M | |
| 658.86M | 388.75M | 77.69M | 126.65M | 83.28M |
Cash flow
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| -322.93M | -142.11M | -76.76M | -41.58M | -72.59M | |
| -174.31M | -205.34M | -587.77M | -624.00K | -306.00K | |
| 617.53M | 381.23M | 86.51M | 620.24M | 77.92M | |
| -657.00K | -139.00K | 98.00K | -624.00K | -306.00K | |
| 120.39M | 33.76M | -577.18M | 576.82M | 5.37M |